Peptide research blog — science-backed articles on peptide mechanisms and findings
Research & Insights

Blog

Science-backed articles on peptide research, mechanisms, and the latest findings from our research team.

Tesamorelin: FDA-Approved GHRH Analog Guide
Growth Hormone PeptidesOctober 13, 2026

Tesamorelin: FDA-Approved GHRH Analog Guide

Tesamorelin is a FDA-approved GHRH analog peptide used to treat HIV-associated lipodystrophy. This guide explores its mechanism, clinical evidence, safety profile, and regulatory status in peptide therapeutics.

16
Sermorelin: GHRH Analog Research Profile
Growth Hormone PeptidesOctober 11, 2026

Sermorelin: GHRH Analog Research Profile

Sermorelin is a synthetic GHRH analog that achieved FDA approval and extensive clinical use. This research profile examines its mechanism of action, clinical evidence, safety profile, and unique regulatory history in peptide therapeutics.

14
MK-677 (Ibutamoren): Growth Hormone Secretagogue
Growth Hormone PeptidesOctober 8, 2026

MK-677 (Ibutamoren): Growth Hormone Secretagogue

MK-677 (ibutamoren mesylate) is an orally active growth hormone secretagogue that functions as a ghrelin receptor agonist. This guide covers its mechanism of action, clinical research evidence, safety profile, and regulatory status across jurisdictions.

17
MGF (Mechano Growth Factor): Research Guide
Growth Hormone PeptidesOctober 6, 2026

MGF (Mechano Growth Factor): Research Guide

MGF (Mechano Growth Factor) is a naturally occurring peptide produced during muscle stress that activates satellite cells and promotes protein synthesis. This research guide covers mechanisms, evidence, safety considerations, and legal status.

20
Ipamorelin: Selective GHRP Research Guide
Growth Hormone PeptidesOctober 2, 2026

Ipamorelin: Selective GHRP Research Guide

Comprehensive guide to ipamorelin as a selective growth hormone releasing peptide. Learn mechanisms, research applications, and evidence-based information for peptide research.

25
IGF-1 LR3: Insulin-Like Growth Factor Profile
Growth Hormone PeptidesSeptember 29, 2026

IGF-1 LR3: Insulin-Like Growth Factor Profile

IGF-1 LR3 is a modified insulin-like growth factor with enhanced bioavailability and extended half-life. This guide explores its structural modifications, mechanisms of action, research findings, and regulatory landscape for scientists and researchers.

27
IGF-1 DES: Truncated IGF Variant Profile
Growth Hormone PeptidesSeptember 25, 2026

IGF-1 DES: Truncated IGF Variant Profile

IGF-1 DES is a naturally occurring truncated variant of insulin-like growth factor-1 with distinct pharmacological properties. This comprehensive profile explores its molecular structure, mechanisms of action, research applications, and regulatory status for peptide researchers.

29
Hexarelin: Potent GHRP Research Profile
Growth Hormone PeptidesSeptember 22, 2026

Hexarelin: Potent GHRP Research Profile

Hexarelin stands as one of the most potent growth hormone-releasing peptides, capable of producing pulses three times larger than GHRH. However, rapid receptor desensitization limits its long-term utility. This comprehensive guide covers mechanisms, research applications, and regulatory status.

35
GHRP-6: Growth Hormone Peptide Research
Growth Hormone PeptidesSeptember 18, 2026

GHRP-6: Growth Hormone Peptide Research

GHRP-6 is a pioneering synthetic peptide that stimulates natural growth hormone release through ghrelin receptor activation. This guide covers its mechanisms, research applications, safety considerations, and regulatory status.

41
GHRP-2: Growth Hormone Releasing Peptide Profile
Growth Hormone PeptidesSeptember 14, 2026

GHRP-2: Growth Hormone Releasing Peptide Profile

GHRP-2 is a synthetic peptide that stimulates natural growth hormone production through ghrelin receptor activation. Learn about its mechanism of action, clinical applications, and safety profile in this comprehensive research overview.

40
Follistatin: Myostatin Inhibitor Research
Growth Hormone PeptidesSeptember 9, 2026

Follistatin: Myostatin Inhibitor Research

Follistatin operates as a myostatin inhibitor by blocking growth-limiting signals rather than directly stimulating muscle. Discover the research, mechanisms, and regulatory landscape surrounding this peptide.

43
CJC-1295 with DAC: Extended-Release Research
Growth Hormone PeptidesSeptember 3, 2026

CJC-1295 with DAC: Extended-Release Research

CJC-1295 with DAC represents a sophisticated extended-release peptide that stimulates growth hormone through albumin-binding DAC technology. Learn about its mechanisms, research evidence, and practical applications in this comprehensive scientific guide.

51